Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study. Issue 15 (1st April 2022)
- Record Type:
- Journal Article
- Title:
- Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study. Issue 15 (1st April 2022)
- Main Title:
- Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study
- Authors:
- Abbatecola, Angela Marie
Incalzi, Raffaele Antonelli
Malara, Alba
Palmieri, Annapina
Di Lonardo, Anna
Fedele, Giorgio
Stefanelli, Paola
Borselli, Gilda
Russo, Marcello
Noale, Marianna
Fumagalli, Stefano
Gareri, Pietro
Mossello, Enrico
Trevisan, Caterina
Volpato, Stefano
Monzani, Fabio
Coin, Alessandra
Bellelli, Giuseppe
Okoye, Chukwuma
Del Signore, Susanna
Zia, Gianluca
Bottoni, Elisa
Cafariello, Carmine
Onder, Graziano - Abstract:
- Abstract: The COVID-19 pandemic has changed routine care practice for older persons, especially in those with frailty living in long term care (LTC) facilities. Due to the high mortality rates of Nursing home (NH) residents during the first wave of the COVID-19 pandemic, priority for COVID-19 vaccinations was given to this vulnerable population. However, the safety and efficacy of such vaccines in older frail elders remains questionable due to the fact that initial randomized clinical trials (RCTs) for such vaccines did not include this population. This type of discrimination in patient participation in RCTs continues and has been recognized in the literature. Nevertheless, in the context of a worldwide emergency, COVID-19 vaccination in older persons living in LTC facilities may provide a solid basis to protect against negative outcomes, such as COVID-19 infection and death. In this report, we present the protocol of the GeroCovid Vax study, an Italian study that began in February 2021 which is aimed at investigating the safety and efficacy of the anti-SARS-CoV-2 vaccinations in older persons living in LTCs. This protocol specially aims to continuously and closely monitor events related to- and following- the anti-SARS-CoV-2 vaccination in elderly living in LTC facilities. In this report, we will provide information related to the study protocol and describe baseline characteristics of the sample.
- Is Part Of:
- Vaccine. Volume 40:Issue 15(2022)
- Journal:
- Vaccine
- Issue:
- Volume 40:Issue 15(2022)
- Issue Display:
- Volume 40, Issue 15 (2022)
- Year:
- 2022
- Volume:
- 40
- Issue:
- 15
- Issue Sort Value:
- 2022-0040-0015-0000
- Page Start:
- 2324
- Page End:
- 2330
- Publication Date:
- 2022-04-01
- Subjects:
- GeroCovid Vax -- COVID-19 vaccine -- Nursing homes (NH) -- Long term care (LTC) -- Frailty syndrome -- Elderly -- Safety
Vaccines -- Periodicals
615.372 - Journal URLs:
- http://www.sciencedirect.com/science/journal/0264410X ↗
http://www.clinicalkey.com/dura/browse/journalIssue/0264410X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0264410X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.vaccine.2022.02.064 ↗
- Languages:
- English
- ISSNs:
- 0264-410X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9138.628000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21279.xml